"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 7 | 2 | 9 |
| 1996 | 5 | 2 | 7 |
| 1997 | 4 | 1 | 5 |
| 1998 | 2 | 4 | 6 |
| 1999 | 4 | 4 | 8 |
| 2000 | 3 | 3 | 6 |
| 2001 | 5 | 1 | 6 |
| 2002 | 9 | 2 | 11 |
| 2003 | 8 | 8 | 16 |
| 2004 | 8 | 3 | 11 |
| 2005 | 8 | 4 | 12 |
| 2006 | 6 | 2 | 8 |
| 2007 | 17 | 7 | 24 |
| 2008 | 15 | 3 | 18 |
| 2009 | 13 | 2 | 15 |
| 2010 | 19 | 3 | 22 |
| 2011 | 16 | 2 | 18 |
| 2012 | 24 | 3 | 27 |
| 2013 | 31 | 3 | 34 |
| 2014 | 31 | 3 | 34 |
| 2015 | 26 | 3 | 29 |
| 2016 | 37 | 4 | 41 |
| 2017 | 32 | 2 | 34 |
| 2018 | 25 | 2 | 27 |
| 2019 | 40 | 4 | 44 |
| 2020 | 44 | 0 | 44 |
| 2021 | 33 | 2 | 35 |
| 2022 | 29 | 1 | 30 |
| 2023 | 32 | 0 | 32 |
| 2024 | 18 | 4 | 22 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature. J Vis Exp. 2025 Jan 24; (215).
-
Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis. Am J Ophthalmol. 2025 Mar; 271:466-477.
-
Loss to Follow-Up in Patients With Proliferative Diabetic Retinopathy or Diabetic Macular Edema. JAMA Netw Open. 2024 Dec 02; 7(12):e2450942.
-
Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis. Am J Ophthalmol. 2025 Mar; 271:138-148.
-
Adiponectin-induced activation of ERK1/2 drives fibrosis in retinal pigment epithelial cells. Hum Cell. 2024 Oct 26; 38(1):8.
-
Laser-Based Therapy Approaches in the Retina: A Review of Micropulse Laser Therapy for Diabetic Retinopathy. Klin Monbl Augenheilkd. 2024 Nov; 241(11):1201-1206.
-
Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis. Ophthalmologica. 2024; 247(5-6):355-372.
-
Differences in macular thickness associated with peripheral retinal vessel whitening in diabetic patients. Sci Rep. 2024 08 27; 14(1):19881.
-
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study. Eye (Lond). 2024 Dec; 38(17):3272-3278.
-
Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S. Curr Opin Ophthalmol. 2024 Sep 01; 35(5):369-375.